An advanced CT test can identify individuals with stable angina at a reduced risk of three-year adverse outcomes despite their having a high coronary artery calcium score, according to a new study. An ...

Please provide your email address to receive an email when new articles are posted on . Abnormal FFR-CT findings were significantly prognostic of poor long-term outcomes in patients with stable angina ...

A routine strategy that assesses function of all epicardial vessels at the time of diagnostic angiography in patients with new-onset chest pain doesn’t cost any more than conventional diagnostic ...

OAK BROOK, Ill. – A new study showed that a non-invasive imaging test can help identify patients with coronary artery blockage or narrowing who need a revascularization procedure. The findings were ...

The company conducted a search of the health economics literature on HeartFlow FFR CT and the comparators specified in the decision problem. They identified a total of 174 studies, 24 of which it ...

A new study showed that a non-invasive imaging test can help identify patients with coronary artery blockage or narrowing who need a revascularization procedure. A new study showed that a non-invasive ...

The company's claimed system benefits included reduced costs from fewer inconclusive or inaccurate diagnostic tests and avoidance of unnecessary staff and procedure costs. It claimed that this would ...

Please provide your email address to receive an email when new articles are posted on . Implementing a CT angiography-derived fractional flow reserve program improved certain outcomes in patients with ...

SAN FRANCISCO, CA – Clinical trial results demonstrate that a non-invasive CTA-based test accurately assesses coronary artery disease with results closely matching those of invasively measured FFR, ...

The PLATFORM trial is a prospective, consecutive cohort study into which researchers enrolled patients with new-onset chest pain and suspected CAD for which noninvasive or invasive assessment had been ...

The $1.5 billion health-tech startup HeartFlow has a noninvasive test for coronary artery disease based on machine learning analysis of CT scans of the heart. It also has a large pile of money to run ...